Dialog Alerts: Delivering Relevant Pharmacovigilance Literature Alerts for Drug Safety Aggregate Reports

Dialog News, DST News, Medical Literature Monitoring

April 14, 2021

Image of pharmacovigilance alert frequency on Dialog Dialog alerts are a central part of our pharmacovigilance literature monitoring solution. They ensure key medical literature is automatically searched on a regular, predictable basis to deliver relevant journal articles for drug safety monitoring. An important part of this is the creation of aggregate reports, used by pharmaceutical and medical device companies for product authorization and ongoing product safety monitoring, including Periodic Safety Update Reports (PSUR); Periodic Benefit-Risk Evaluation Report (PBRER); and Development Safety Update Reports (DSUR). Dialog alerts helps optimise the systematic review process, reducing the risk of missing safety findings and report due dates.

Given the important role Dialog alerts play in pharmacovigilance literature monitoring, we’re pleased to announce a further enhancement to Dialog alerts – an even greater range of alert frequencies. You can now choose to receive alerts every 4 hours, daily, weekly, or every 1, 3, 6 or 12 months. And you can completely customise the exact day and hour that you’ll receive your aggregate report searches as alerts, ensuring they fit perfectly into your drug safety monitoring workflow.

Like all Dialog alerts, the new frequency options for aggregate reports include high precision, high recall searches that retrieve clinical and non-clinical studies, conference papers, peer-reviewed scientific literature, and unpublished manuscripts from the following sources:

MEDLINE | Embase | ClinicalTrials.gov (coming soon) | BIOSIS Previews | Derwent Drug File | SciSearch | Northern Light Life Science Conference Abstracts | Allied and Complementary Medicine | International Pharmaceutical Abstracts | Morressier Life Science Conference Abstracts and Posters

Who should use Dialog alerts for drug safety aggregate reports?

Pharmaceutical and medical device companies and the CROs that support them, for product authorization and ongoing benefit-risk product monitoring.

Benefits of using Dialog for literature alerts for pharmacovigilance:

  1. Get one collated set of literature at defined time points, aligned with report submission date
  2. Lower the risk of missing safety relevant references
  3. De-duplication of the search results
  4. Simplify record keeping and maintenance for your aggregate reporting process
  5. Reduce risk of inspection findings by regulatory authorities

By working with Dialog Solutions, you can use Drug Safety Triager to ingest, organize, and review literature for aggregate reports in a GxP environment. What’s more, Drug Safety Triager integrates with full text providers (like Article Galaxy from Research Solutions) for seamless full text retrieval.

Short on time? Dialog’s alert service will help you set up your alerts

If you’re short on time or need extra support, we can work with you to create and maintain your pharmacovigilance literature monitoring search strategies and alerts to ensure you’re getting the results you need. Our experienced team works with pharmaceutical companies to help them set up searches and alerts to track their products for drug safety reporting.

If you’re an existing customer, email customer@dialog.com or contact your Dialog account manager for a personalized demo and training on how to use Dialog’s alerts to help deliver the literature for your drug safety reports.

If you’re not currently a Dialog or Drug Safety Triager customer but want to find out how we can streamline your drug safety monitoring workflow, get in touch with us at sales@dialog.com.

To learn more about our pharmacovigilance solutions, take a look at this overview of our end-to-end approach to literature monitoring.

If you’d like to discuss how we can help with your drug safety literature monitoring, drop us an email at sales@dialog.com or use the contact form.